| 注册
首页|期刊导航|转化医学杂志|中药单成分治疗原发性骨肿瘤骨破坏的研究进展

中药单成分治疗原发性骨肿瘤骨破坏的研究进展

白洋 周猷 申玉行 张智海

转化医学杂志2025,Vol.14Issue(1):268-272,5.
转化医学杂志2025,Vol.14Issue(1):268-272,5.DOI:10.3639/i.issn.2095-3097.2025.01.053

中药单成分治疗原发性骨肿瘤骨破坏的研究进展

Research Progress of a Single Component of Traditional Chinese Medicine in the Treatment of Bone Destruction Caused by Primary Bone Tumors

白洋 1周猷 2申玉行 1张智海2

作者信息

  • 1. 102202 北京,北京市昌平区南口医院骨科
  • 2. 100055 北京,中国中医科学院广安门医院骨科
  • 折叠

摘要

Abstract

Primary bone tumor refers to the tumor originated from bone tissue,and the common primary bone tumors include osteosarcoma,chondrosarcoma,osteoblastoma and so on.Among them,malignant tumors account for a high proportion,and characterized as rapid onset,poor prognosis and high mortality.This review described latest research progress of the single component of traditional Chinese medicine in the treatment of bone destruction caused by primary bone tumors,including tanshinone,panax notoginseng saponins,Astragalus polysaccharides,Astragaloside IV,triptolide,paclitaxel,curcumin,resveratrol,matrine,angelicin,and naringenin,aiming to provide references for clinical treatment and drug development.

关键词

中药单成分/原发性骨肿瘤/骨破坏/研究进展

Key words

Single component of traditional Chinese medicine/Primary bone tumor/Bone destruction/Research progress

分类

医药卫生

引用本文复制引用

白洋,周猷,申玉行,张智海..中药单成分治疗原发性骨肿瘤骨破坏的研究进展[J].转化医学杂志,2025,14(1):268-272,5.

转化医学杂志

2095-3097

访问量0
|
下载量0
段落导航相关论文